Pilot study explores early induction for gestational diabetes
NCT ID NCT06641141
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing whether it's practical to run a larger trial that compares inducing labor at 38 weeks versus waiting for natural labor in people with gestational diabetes. About 260 participants will be randomly assigned to either early induction or expectant management. The main goal is to see if enough people can be recruited and if the study procedures work well, not to determine if one approach is safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Induction of labour (a procedure to start labor using medications or techniques)
What this could lead to
If successful, this pilot could pave the way for a larger trial that may show whether inducing labor at 38 weeks improves outcomes for mothers with gestational diabetes.
What could go wrong
This is a small pilot study focused on feasibility, not on proving safety or effectiveness. Results may not apply to all patients, and the larger trial may still fail to show benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••